Skip to content

Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis

Comparison of Pulmonary Rehabilitation Efficiency in Home-based With Hospital-based Pulmonary Rehabilitation in Bronchiectasis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03561818
Enrollment
50
Registered
2018-06-19
Start date
2018-06-19
Completion date
2026-12-30
Last updated
2025-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis, Pulmonary Rehabilitation, Lung Diseases, Lung Diseases, Interstitial

Brief summary

The investigators aimed to compare the home-based Pulmonary Rehabilitation with the hospital-based pulmonary rehabilitation in terms of pulmonary rehabilitation efficiency in patient with bronchiectasis.

Detailed description

While the benefits of pulmonary rehabilitation (PR) in cases of chronic obstructive pulmonary disease (COPD) have been well-documented, there have been only a limited number of studies investigating the efficacy of PR in patients with bronchiectasis. Some of these studies have reported positive effects of PR also in bronchiectasis patients, but have underlined the need for additional studies including larger patient groups to define PR indications, and to ensure that exercise protocols are specific for this patient group. There are many PR organizational types, such as hospital-based, telephone-mentoring with home-based or tele monitorization programs. Hospital-based supervised programs are time-consuming and costly practices. For this reason, there is a need for further studies on the effectiveness and benefits of unsupervised programs. In this study, we will compare unsupervised home-based PR and supervised hospital-based PR in terms of pulmonary rehabilitation effectiveness. The pulmonary function tests, dyspnea perception, quality of life and exercise capacity assessments will performed before and after pulmonary rehabilitation.

Interventions

The patients who undergo two days pulmonary rehabilitation under supervision in our clinic and three days a week at home during two months will taken as hospital group. The exercises include breathing exercises, treadmill (15sc), cycle training (15sc), arm ergometer training (15sc), peripheral muscle training and stretching exercises with free weights.

The patients who follow a home-based pulmonary rehabilitation program for two months comprising breathing exercises, training in chest hygiene techniques, peripheral muscle strengthening training and self-walking for 5 days in a week for two months. An exercise follow-up form will give to the patients to record their daily exercises. A similar form will fill by physiotherapist once a week during phone call.

Sponsors

Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 18-70 * Patients signing informed consent form * Bronchiectasis patients in the stable phase who were diagnosed with High-resolution computed tomography (HRCT).

Exclusion criteria

* Decompensated heart failure, uncontrolled hypertension (Systolic Blood Pressure\> 200, Diastolic Blood Pressure\> 110), * Additional diseases that may prevent exercise, * To be regularly exercising regularly

Design outcomes

Primary

MeasureTime frameDescription
Changes from baseline the 6-minute walking distance at two months.Two months
Changes from baseline the modified Medical Research Council (mMRC) scale at two months.Two monthsDyspnea perceptions during daily life activities will assess according to the modified Medical Research Council (mMRC) scale. The mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. 0 means no dyspnea perception, 4 means severe dyspnea perception.

Secondary

MeasureTime frameDescription
Changes from baseline the forced expiratory volume in one second at two months.Two monthsThe Pulmonary Function Test conducted using a Sensor Medics model 2400 device (Yorba Linda, CA, USA), in line with American Thoracic Society (ATS) guidelines.
Changes from baseline the peripheral muscle strength at two months.Two monthsPeripheral Muscle Strength will measure using a digital dynamometer(J-Tech Commander muscle testing device), with three measurements make in total of the quadriceps femoris, tibialis anterior and iliopsoas muscles.
Changes from baseline the Quality of Life at two months.Two monthsSt. George Respiratory Questionnaire

Countries

Turkey (Türkiye)

Contacts

Primary ContactEsra Pehlivan, PhD
fztesrakambur@yahoo.com+905058527913

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026